As of August 28, 2026, MoonLake Immunotherapeutics (MLTX) has a DilutionWatch DilutionScore of 30/100, rated MEDIUM dilution risk. MoonLake Immunotherapeutics has a market capitalization of $1.41B, 85.11M shares outstanding, 150 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for MLTX.
Market Data
Market Cap$1.41B
Shares Outstanding85.11M
Float38.25M
Cash$477.90M
Debt$99.51M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 19.4% shares (2026Q1 vs prior)
150 institutional holders · 71.93M shares
#1
BVF INC/IL
16.00M shares
#2
JANUS HENDERSON GROUP PLC
6.90M shares
#3
Deep Track Capital, LP
6.41M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest5.72M
Days to Cover6.6
% of Float15.0%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2024-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual MLTX Dilution Snapshot
MoonLake Immunotherapeutics (MLTX) has a DilutionScore of 30/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for MLTX: xbrl on 2024-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track MLTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MLTX — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for MLTX
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.